LOGO-01.png
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
03 juin 2024 00h41 HE | Burning Rock Biotech Limited
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
LOGO-01.png
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
30 mai 2024 03h42 HE | Burning Rock Biotech Limited
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
Corporate structure reorganization
Burning Rock Reports First Quarter 2024 Financial Results
29 mai 2024 01h34 HE | Burning Rock Biotech Limited
Burning Rock Reports First Quarter 2024 Financial Results
LOGO-01.png
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
23 mai 2024 02h00 HE | Burning Rock Biotech Limited
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
LOGO-01.png
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
14 mai 2024 02h02 HE | Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
LOGO-01.png
Burning Rock Publishes 2023 Annual Report on Form 20-F
29 avr. 2024 03h30 HE | Burning Rock Biotech Limited
Burning Rock Publishes 2023 Annual Report on Form 20-F
LOGO-01.png
Burning Rock Announces ADS Ratio Change
26 avr. 2024 01h59 HE | Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change
LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
28 mars 2024 17h16 HE | Burning Rock Biotech Limited
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
LOGO-01.png
Burning Rock Announces Receipt of Notification from NASDAQ
04 janv. 2024 01h03 HE | Burning Rock Biotech Limited
Burning Rock Announces Receipt of Notification from NASDAQ
LOGO-01.png
Burning Rock Announces Results of 2023 Annual General Meeting
19 déc. 2023 21h35 HE | Burning Rock Biotech Limited
Burning Rock Announces Results of 2023 Annual General Meeting